November 01, 2017
Oncopeptides to present data from two clinical studies of Ygalo® (melflufen) at American Society of Hematology (ASH), December 9-12
Media
November 01, 2017
Nordic Nanovector: Updated results from Phase 1/2 trial of Betalutin® in non-Hodgkin lymphoma to be presented at ASH in December
October 31, 2017
Orexo issues bonds of SEK 325 million and confirms fulfilment of condition under notice of early redemption
October 26, 2017
Onxeo Provides Strategy Update and Reports 2017 Third Quarter Financial Information
October 26, 2017
GenSight Biologics Reports its Cash Position as of September 30, 2017
October 26, 2017
Cash position and activity update for Q3 2017
October 25, 2017
Nexstim raises EUR 1.75 million via a directed issue of new shares to London-based investor City Financial – Funds to be used to support beginning the commercialisation of its NBT® system
October 25, 2017
GenSight Biologics Appoints Barrett Katz as Chief Medical Officer
October 24, 2017
Targovax ASA: Invitation to third quarter 2017 results presentation Thursday 2 November
October 23, 2017
Nordic Nanovector: Presentations at European Association of Nuclear Medicine annual meeting (EANM)